EMSY | bioCADDIE Data Discovery Index
Mountain View
biomedical and healthCAre Data Discovery Index Ecosystem
help Advanced Search
Displaying 7 of 7 results for "EMSY"
i
  1. Crystal Structure of EMSY-HP1 complex PDB

    ID: PDB:2FMM

    Description: Protein EMSY, Chromobox protein homolog 1

  2. CRYSTAL STRUCTURE OF NOVEL PROTEIN EMSY PDB

    ID: PDB:1UZ3

    Description: EMSY PROTEIN

  3. CRYSTAL STRUCTURE OF NOVEL PROTEIN EMSY TRUNCATE PDB

    ID: PDB:1UTU

    Description: EMSY

  4. Ovarian Cancer CGH ArrayExpress

    ID: E-GEOD-16408

    Description: of other genes. Here, we investigate the role of EMSY, a recently described BRCA2 interacting protein, as a key element of the 11q13 amplicon in ovarian cancer. EMSY maps to 11q13.5 and is amplified in 13% of breast and 17% of ovarian carcinomas. METHODS: EMSY amplification was assessed by fluorescent in-situ hybridization (FISH) in 674 ovarian cancers in a tissue microarray and correlated with histopathological subtype and tumor grade. A detailed map of the 11q13 amplicon in 51 cases of ovarian cancer was obtained using cDNA-array...

  5. Ovarian Cancer CGH BioProject

    ID: PRJNA116307

    Keywords: Variation

    Access Type: download

    dataset.description: of other genes. Here, we investigate the role of EMSY, a recently described BRCA2 interacting protein, as a key element of the 11q13 amplicon in ovarian cancer. EMSY maps to 11q13.5 and is amplified in 13% of breast and 17% of ovarian carcinomas. METHODS: EMSY amplification was assessed by fluorescent in-situ hybridization (FISH) in 674 ovarian cancers in a tissue microarray and correlated with histopathological subtype and tumor grade. A detailed map of the 11q13 amplicon in 51 cases of ovarian cancer was obtained using cDNA-array...
  6. Ovarian Cancer CGH OmicsDI

    ID: E-GEOD-16408

    Date Released: 05-01-2014

    Description: of other genes. Here, we investigate the role of EMSY, a recently described BRCA2 interacting protein, as a key element of the 11q13 amplicon in ovarian cancer. EMSY maps to 11q13.5 and is amplified in 13% of breast and 17% of ovarian carcinomas. METHODS: EMSY amplification was assessed by fluorescent in-situ hybridization (FISH) in 674 ovarian cancers in a tissue microarray and correlated with histopathological subtype and tumor grade. A detailed map of the 11q13 amplicon in 51 cases of ovarian cancer was obtained using cDNA-array...

  7. EMSY_DANRE UniProt:Swiss-Prot

    ID: Q7ZUV7

    Description: BRCA2-interacting transcriptional repressor EMSY ENT Ser-rich Thr-rich Ser-rich


Displaying 7 of 7 results for "EMSY"